Case 1: Introduction
Welcome to the Breast Cancer Clinical Case Review, a series of case presentations by clinicians in the field of breast cancer.
In this video, Mridula George, MD, assistant professor of medicine at Rutgers Robert Wood Johnson Medical School, and associate program director for breast medical oncology program in the division of medical oncology at Rutgers Cancer Institute of New Jersey, introduces the case: Management of HER2-positive Metastatic Breast Cancer.
Editor’s note: The following is an automatically generated transcript of the above video.
"Hello, everyone. My name is Mridula George. I'm one of the breast medical oncologists at the Rutgers Cancer Institute of New Jersey. I would like to welcome you to my presentation on the management of HER2 positive metastatic breast cancer. I would like to thank Helio for this opportunity to share this patient case. These are my financial disclosures. So an outline of presentation today, we'll be discussing treatment options for de-novo HER2 positive metastatic breast cancer. We'll be discussing briefly about management of treatment related toxicities and treatment options at the time of progression after first line therapy."
Click Here to Manage Email Alerts